Womens Imaging: Page 112

Diagnostics growth drives Hologic's Q1 results higher

By AuntMinnie.com staff writers

Strong growth in its molecular diagnostics business -- with revenues almost tripling due to the COVID-19 pandemic -- helped drive first-quarter preliminary financial results for Hologic. Revenues in the company's Breast Health business edged up slightly.

January 7, 2021

CT/ultrasound fusion enhances ovarian biopsies

By Erik L. Ridley

A method that combines CT radiomics and real-time CT/ultrasound image fusion can yield more accurate and efficient tissue biopsies in ovarian cancer patients and may, in the future, even facilitate "virtual" biopsies, according to research published online December 14 in European Radiology.

January 7, 2021

QT Imaging announces EMEA distribution agreement

By AuntMinnie.com staff writers

Transmission ultrasound breast imaging developer QT Imaging has named Dutch firm Freedom Ventures as exclusive distributor of its QTscan device for the European, Middle Eastern, and North African markets (EMEA). Freedom Ventures will do business as QT Scan.

January 6, 2021

6 factors that influence who gets routine mammography

By Theresa Pablos

Researchers identified six psychological and socioeconomic factors that influence whether a woman is more or less likely to undergo regular screening mammography. The Turkish research team published their findings on January 2 in Perspectives in Psychiatric Care.

January 6, 2021

CIVCO and Philips Healthtech team up

By AuntMinnie.com staff writers

CIVCO Medical Solutions and Philips Healthtech have partnered to advance the availability of CIVCO's Astra automated disinfection system for ultrasound probes within North America.

January 5, 2021

Family breast cancer history tied to mammo usage

By Theresa Pablos

Should women with a family history of breast cancer qualify for additional screening mammography? A December 24 study in the Breast found these moderate-risk patients underwent more mammograms and had a higher rate of screen-detected cancers than their lower-risk peers.

January 5, 2021

Hologic buys Biotheranostics molecular testing firm

By AuntMinnie.com staff writers

Hologic continues to start 2021 with a bang. The company announced on January 5 that it is acquiring Biotheranostics, a developer of molecular tests for breast and metastatic cancer, for $230 million.

January 4, 2021

QT Ultrasound points to breast screening study

By AuntMinnie.com staff writers

Ultrasound technology developer QT Ultrasound said that its transmission ultrasound system yielded higher diagnostic performance than full-field digital mammography in the first-in-human study of the technology for breast cancer screening.

January 4, 2021

Hologic acquires Somatex for $64M

By AuntMinnie.com staff writers

Hologic has acquired Somatex Medical Technologies, a firm specializing in biopsy site markers and localization technologies.

January 3, 2021

SmartBreast acquires molecular breast tech from Dilon

By AuntMinnie.com staff writers

Private breast cancer screening firm SmartBreast has acquired molecular breast imaging technologies and patents from developer Dilon Diagnostics.

January 3, 2021

COVID-19 relief bill delays USPSTF mammo recommendation

By AuntMinnie.com staff writers

A bill passed by the U.S. Congress to provide COVID-19 relief also includes a provision to continue delaying a controversial recommendation by the U.S. Preventive Services Task Force (USPSTF) to begin biennial breast cancer screening at age 50.

December 23, 2020

DBT doesn't find more cancers in breast cancer survivors

By Theresa Pablos

The benefits of digital breast tomosynthesis (DBT) may be limited for finding additional cancers in breast cancer survivors, according to a December 22 study in Radiology. While DBT led to fewer recalls, the modality didn't boost the cancer detection rate for this high-risk population.

December 23, 2020

Previous Page

Page 112 of 694

Next Page